AstraZeneca takes a £1.5bn stake in US cancer drug developer as it steps up investment in America

Дата публикации: 29-09-2026 21:01:17

The British drugs company has ploughed £1.5bn into US pharma firm Summit Therapeutics as part of a cancer treatment research joint venture.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Two more UK firms open the door to private equity takeovers in what would mean a £1bn blow to the City	0	9.84	29-09-2026
2	Fresenius Takes Full Control Of Spanish Biz In €750M Deal	0	9.13	01-10-2026
3	GSK to establish new flagship R&D centre on Cambridge Biomedical Campus, UK	0	12.94	28-07-2026
4	Goodfellow invests over £1.5M into US advanced manufacturing hub	0	11.38	01-10-2026
5	GSK and LTZ announce strategic collaboration to advance novel myeloid cell engagers in oncology	0	7.12	19-11-2025
6	Radiopharmaceutical Dealmaking Continues With Telix’s $1.65B ITM Acquisition	0	8.67	22-09-2026
7	GSK enters agreement to acquire RAPT Therapeutics	0	8.62	20-01-2026
8	Samfara Completes Acquisition Of Chr. Olesen Synthesis, Danish Manufacturer Of Controlled-Substance Apis	0	13.47	02-10-2026
9	Samfara Completes Acquisition Of Chr. Olesen Synthesis, Danish Manufacturer Of Controlled-Substance Apis	0	13.47	02-10-2026
10	Vote of confidence in British car industry as Nissan and McLaren announce £700m investment boost	0	5.22	17-09-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.16. Источник: www.dailymail.co.uk.